Intensive insulin therapy for critically ill patients

Annals of Pharmacotherapy

Volumn 38, Issue 7-8, 2004, Pages 1243-1251

  Lewis, Kelly S ^a,b   Kane Gill, Sandra L ^c   Bobek, Mary Beth ^d   Dasta, Joseph F ^e  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b Actelion Pharmaceuticals US Inc   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d NEW HANOVER REGIONAL MEDICAL CENTER   (United States)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

Hyperglycemia; Insulin infusions; Intensive care unit

Indexed keywords

GLUCOSE; INSULIN;

CRITICAL ILLNESS; DIABETES MELLITUS; DRUG MONITORING; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; CLINICAL TRIALS; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFECTION CONTROL; INSULIN; POSTOPERATIVE COMPLICATIONS;

EID: 3042685712     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1D211     Document Type: Review

References (111)

1. Dasta JF, Durtschi AJ, Kane-Gill SL. Pharmacoeconomics in critical care. In: Grenvik A, ed. Textbook of critical care. 5th ed. Amsterdam: Elsevier, 2004 (in press).
2. Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003;31(1 suppl):S17-24.
3. Dasta JF, Cooper LM. Impact of drotrecogin alfa (activated) on resource use and implication for reimbursement. Pharmacotherapy 2002;(12 part 2):216S-22S.
4. Das UN. Insulin and the critically ill. Crit Care 2002;6:262-3.
5. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001;15:533-51.
6. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolfe SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma 2001;51:540-4.
7. Ljungqvist O, Nygren J, Thorell A. Insulin resistance and elective surgery. Surgery 2000;128:757-60.
8. Kagansky N, Levy S, Knobler H. The role of hyperglycemia in acute stroke. Arch Neurol 2001;58:1209-12.
9. Capes SE, Hunt D, Malmerg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
10. Parsons MW, Barber PA, Desmond PM, Baird TA, Darby DG, Byrnes G, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol 2002;52: 20-8.
11. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ 1997;314:1303-6.
12. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 1999;99:2626-32.
13. Williams LS, Rotich J, Qi R, Fineberg N, Espay A, Bruno A, et al. Effects on admission hyperglycaemia on mortality and costs in acute ischemic stroke. Neurology 2002;59:67-71.
14. Zindrou D, Taylor KM, Bagger JP. Admission plasma glucose: an independent risk factor in nondiabetic women after coronary artery bypass grafting. Diabetes Care 2001;24:1634-9.
15. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9: 1-9.
16. Carter EA. Insulin resistance in burns and trauma. Nutr Rev 1998;56:(1 pt 2):S170-6.
17. Ljungqvist O, Sandberg E, Nylander G, Ware J. Glucose kinetics in haemorrhagic hyperglycemia. Circ Shock 1989;28:347-56.
18. Thorell A, Nygren J, Ljungqvist O. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care 1999;2:69-78.
19. Thorell A, Loftenius A, Andersson B, Ljungqvist O. Postoperative insulin resistance and circulating concentrations of stress hormones and cytokines. Clin Nutr 1996;15:55-9.
20. Jeevanandam M, Young DH, Schiller WR. Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma Inj Infec Crit Care 1990;30:582-9.
21. Gelfand RA, Matthews DE, Bier DM, Sherwin RS. Role of counterregulatory hormones in the catabolic response to stress. J Clin Invest 1984; 74:2238-48.
22. Shamoon H, Hendler R, Sherwin RS. Synergistic interactions among anti-insulin hormone in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab 1981;52:1235-41.
23. McGuinness OP, Fugiwara T, Murrell S, Bracy D, Neal D, O'Connor D, et al. Impact of chronic stress hormone infusion on hepatic carbohydrate metabolism in the conscious dog. Am J Physiol 1993;265(2 pt 1):E314-22.
24. Wolfe RR. Herman Award Lecture, 1996: relation of metabolic studies to clinical nutrition-the example of burn injury. Am J Clin Nutr 1996; 64:800-8.
25. Jahoor F, Herndon DN, Wolfe RR. Role of insulin and glucagons in the response of glucose and alanine kinetics in burn injured patients. J Clin Invest 1986;78:807-14.
26. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994;43:1271-8.
27. Sherwin RS, Sacca L. Effect of epinephrine on glucose metabolism in humans: contribution of the liver. Am J Physiol 1984;247(2 pt 1):E157-65.
28. Connolly CC, Steiner KE, Stevenson RW, Neal DW, Williams PE, Alberti KG, et al. Regulation of lipolysis and ketogenesis by norepinephrine in conscious dogs. Am J Physiol 1991;261(4 pt 1):E466-72.
29. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care 2002;25:583-93.
30. Ekstrand AV. Effect of steroid therapy on insulin sensitivity in insulin-dependent diabetic patients after kidney transplantation. J Diab Complications 1991;5:244-8.
31. Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J, et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997;21:91-5.
32. Frankenfield DC, Reynolds HN, Badellino NM, Wiles CE. Glucose dynamics during continuous hemodiafiltration and total parenteral nutrition. Intensive Care Med 1995;21:1016-22.
33. Manji S, Shikora S, McMahon M, Blackburn GL, Bistrian BR. Peritoneal dialysis for acute renal failure: overfeeding resulting from dextrose absorbed during dialysis. Crit Care Med 1990;18:29-31.
34. Engquist A, Brandt MR, Fernandes A, Kehlet H. The blocking effect of epidural analgesia on the adrenocortical and hyperglycemic responses to surgery. Acta Anaesthesiol Scand 1977;21:330-5.
35. Kehlet H, Brandt MR, Prange-Hansen A, Alberti KG. Effect of epidural analgesia on metabolic profiles during and after surgery. Br J Surg 1979;66:543-6.
36. Giesecke K, Hamberger B, Jarnberg PO, Klingstedt C, Persson B. High- and low-dose fentanyl anaesthesia: hormonal and metabolic responses during cholecystectomy. Br J Anaesth 1988;61:575-82.
37. Schricker T, Carli F, Sheiber M, Wachter U, Geisser W, Lattermann R, et al. Propofol/sufentanil anesthesia suppresses the metabolic and endocrine response during, not after, lower abdominal surgery. Anesth Analg 2000;90:450-5.
38. Lattermann R, Schricker T, Wachter U, Georgieff M, Goertz A. Understanding the mechanisms by which isoflurane modifies the hyperglycemic response to surgery. Anesth Analg 2001;93:121-7.
39. Werb MR, Zinman B, Teasdale SJ, Goldman BS, Scully HE, Marliss EB. Hormonal and metabolic responses during coronary artery bypass surgery: role of infused glucose. J Clin Endocrinol Metab 1989;69:1010-8.
40. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, et al. Differentiation between septic and postburn insulin resistance. Metabolism 1989;38:983-9.
41. Rao V, Merante F, Weisel RD, Shirai T, Ikonomidis JS, Cohen G, et al. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia. J Thorac Cardiovasc Surg 1998;116:485-94.
42. Sakurai Y, Aarsland A, Herndon DN, Chinkes DL, Pierre E, Nguyen TT, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg 1995;222:283-97.
43. Aarsland A, Chinkes D, Wolfe RR, Barrow RE, Nelson SO, Pierre E, et al. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 1996;223:777-89.
44. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Edocrinol Metab 2003;88:1082-8.
45. Das UN. Current advances in sepsis and septic sepfic shock with particular emphasis on the role of insulin. Med Sci Monit 2003;9:RA181-92.
46. Davi G, Catalano I, Averna M, Notarbartolo A, Stano A, Ciabattoni G, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 1990;322:1769-74.
47. Vague P, Raccah D, Juhan-Vague I. Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis. Metabolism 1992;41(suppl):2-6.
48. Jain SK, Nagi DK, Slavin BM, Lumb PJ, Yudkin JS. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control. Diabet Med 1993;10:27-32.
49. Satomi N, Sakurai A, Haranaka K. The relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: the role of glucose, insulin, and macrophages. J Natl Cancer Inst 1985;74:1255-60.
50. Das UN. Is insulin an anti-inflammatory molecule? Nutrition 2001;17: 409-13.
51. Woo E, Chan YW, Yu YL, Huang CY. Admission glucose level in relation to mortality and morbidity outcome in 252 stroke patients. Stroke 1988;19:185-91.
52. Rovlias A, Kotsou S. The influence of hyperglycemia on neurologic outcome in patients with severe head injury. Neurosurgery 2000;46:335-43.
53. Ginsberg MD, Prado R, Dietrich WD, Busto R, Waton BD. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke 1987; 18:570-4.
54. Venables GS, Miller SA, Gibson G, Hardy JA, Strong AJ. The effects of hyperglycaemia on changes during reperfusion following focal cerebral ischaemia in the cat. J Neurol Neurosurg Psychiatry 1985;48:663-9.
55. Chew W, Kucharczyk J, Moseley M, Derugin N, Norman D. Hyperglycemia augments ischemic brain injury: in vivo MR imaging/spectroscopic study with nicardipine in cats with occluded middle cerebral arteries. AJNR Am J Neuroradiol 1991;12:603-9.
56. DeCourten-Meyers GM, Kleinholz M, Wagner KR, Myers RE. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab 1994;14:227-36.
57. Prado R, Ginsberg MD, Dietrich WD, Watson BD, Busto R. Hyperglycemia increases infarct size in collaterally perfused but not end-arterial vascular territories. J Cereb Blood Flow Metab 1988;8:186-92.
58. Warner DS, Todd MM, Dexter F, Ludwig P, McAllister AM. Temporal thresholds for hyperglycemia-augmented ischemic brain damage in rats. Stroke 1995;26:655-60.
59. Pulsinelli WA, Waldman S, Rawlinson D, Plum F. Moderate hyperglycemia augments ischemic brain damage: a neuropathologic study in the rat. Neurology 1982;32:1239-46.
60. 2 modulation on cortical intracellular acidosis, NADH redox state, and infarction in the ischemic penumbra. Stroke 1999;30:160-70.
61. Bruno BA, Levin MR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al. Admission glucose level and clinical outcomes in the NINDS rt-PA stroke trial. Neurology 2002;59:669-74.
62. Sieber FE, Traystman RJ. Special issues: glucose and the brain. Crit Care Med 1992;20:104-14.
63. Goodman JC, Valadaka AB, Gopinath SP, Uzura M, Robertson CS. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis. Crit Care Med 1999;27:1965-73.
64. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KG, Gray CS. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin Stroke Trial (GIST). Stroke 1999;30:793-9.
65. Gupta DK, Jewitt DE, Young R, Hartog M, Opie LH. Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet 1969;2:1209-13.
66. Valori C, Thomas M, Shillingford J. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction. Am J Cardiol 1967;20:605-17.
67. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
68. Rackley CE, Russel R, Rogers WJ, Mantle JA, McDaniel HG, Papapietro SE. Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 1981;102(6 pt 1):1038-49.
69. Van der Horst IC, Zijlstra F, Van'tHof AW, Doggen CJ, deBoer MJ, Suryapranata H, et al. Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction: the Glucose-Insulin-Potassium study: a randomized trial. J Am Coll Cardiol 2003;42:784-91.
70. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, et al. Anti-inflammatory and profibrinolytic effect of insulin in acute ST-segment-elevation myocardial infarction. Circulation 2004; 109:849-54.
71. Sundell J, Knuuti J. Insulin and myocardial blood flow. Cardiovasc Res 2003;57:312-9.
72. Sievers J, Lindh J, Johanson BW, Karnell J. Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion. Cardiology 1966; 49:239-47.
73. Pentacost BL, Mayne NM, Lamb P. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet 1968;1:946-8.
74. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997;96:1152-6.
75. Diaz R, Paolasso E, Piegas LS, Tajer CD, Morena MG, Corvalan R, et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998;98:2227-34.
76. Apstein CS. The benefits of glucose-insulin-potassium for acute myocardial infarctions (and some concerns). J Am Coll Cardiol 2003;42: 792-5.
77. Castro PF, Larrain G, Baeza R, Corbalan R, Nazzal C, Greig DP, et al. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty. Crit Care Med 2003;31:2152-5.
78. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P, Waldenstrom A, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
79. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ 1997;314:1512-5.
80. Doenst T, Bothe W, Beyersdorf F. Therapy with insulin in cardiac surgery: controversies and possible solutions. Ann Thorac Surg 2003;75: S721-8.
81. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003;78:1471-8.
82. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996;110:1173-8.
83. L'Ecuyer PB, Murphy D, Little JR, Fraser VJ. The epidemiology of chest and leg wound infections following cardiothoracic surgery. Clin Infect Dis 1996;22:424-9.
84. Shimada M, Matsumata T, Akazawa K, Kamakura T, Itasaka H, Sugimachi K, et al. Estimation of risk of major complications after hepatic resection. Am J Surg 1991;167:399-403.
85. Fietsam R, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg 1991;57:551-7.
86. Black E, Vibe-Petersen J, Jorgensen LN, Madsen SM, Argen MS, Holstein PE, et al. Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg 2003;138:34-40.
87. Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990;30:830-2.
88. Port D, Schwartz MW. Diabetes complications: why is glucose potentially toxic? Science 1996;272:699-700.
89. Hostetter MK. Handicaps to host defense. Effects of hyperglycemia on C3 and Candida albicans. Diabetes 1990;39:271-5.
90. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. J Parenter Enteral Nutr 1991;15:60-4.
91. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP. Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 2002;94:1113-9.
92. Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 1974;23:9-15.
93. Bagdade JD, Stewart M, Walters E. Impaired granulocyte adherence. A reversible defect in host defense in patients with poorly controlled diabetes. Diabetes 1978;27:677-81.
94. Sima AA, O'Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes 1988;37:544-9.
95. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med 1971;284:621-7.
96. Delamaire M, Maugendre D, Moreno M, LeGoff MC, Allanie H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14:29-34.
97. Nolan CM, Beaty HN, Bagdade JD. Further characterization of the impaired bactericidal function of granulocytes in patients with poorly controlled diabetes. Diabetes 1978;27:889-94.
98. Davidson NJ, Sowden JM, Fletcher J. Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins. J Clin Pathol 1984;37:783-6.
99. Drachman RH, Root RK. Wood WB. Studies on the effect of experimental nonketotic diabetes mellitus on antibacterial defense. J Exp Med 1966;124:227-40.
100. MacRury SM, Gemmell CG, Paterson KR, MacCuish AC. Changes in phagocytic function with glycaemic control in diabetic patients. J Clin Pathol 1989;42:1143-7.
101. Golden SJ, Peart-Vigilance C, Kao WH, Brancati FL. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999;22:1408-14.
102. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:352-61.
103. Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999;67:352-62.
104. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.
105. Bronsveld W, Van den Bos GC, Thijs LG. Use of glucose-insulin-potassium (GIK) in human septic shock. Crit Care Med 1985;13:566-70.
106. Kobayashi H, Yoshioka T, Maemura K, Ohashi N, Sawada Y, Sugimoto T. Hemodynamic and diuretic effects of GIK (glucose-insulin-potassium) treatment on extensive burn patients. J Trauma Injury Infect Crit Care 1983;23:116-22.
107. van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003;31: 359-66.
108. Augustin R, Pocar P, Wrenzycki C, Niemann H, Fischer B. Mitogenic and anti-apoptotic activity of insulin on bovine embryos produced in-vitro. Reproduction 2003;126:91-9.
109. Allen DA, Harwood S, Varagunam M, Raftery MJ, Yaqoob MM. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 2003;17: 908-10.
110. Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA 2003;290:2041-7.
111. Cohen MR, Proulx SM, Crawford SY. Survey of hospital system and common serious medication errors. J Healthc Risk Manag 1998;18:16-27.